Post by IQVIA

A rare liver disease (AATD-related liver disease) is often missed because symptoms overlap with more common conditions. Takeda leveraged IQVIA Healthcare-grade AI® to develop an AI tool to help clinicians identify patients earlier, improving detection rates by up to 233x in liver disease patients and over 9300x in the general population. Learn more about this study in Takeda’s abstract #3655: https://lnkd.in/eN89RV8k